Stay updated on Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Sign up to get notified when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.

Latest updates to the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the PRECISION 1 nab-sirolimus trial, including its completed status, posted results, eligibility criteria, study outcomes, locations, and study documents.SummaryDifference100%

- Check19 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA notice about NIH website changes and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov study record page.SummaryDifference1%

- Check33 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check54 days agoChange DetectedThere are no additions or deletions to report for this page based on the provided data.SummaryDifference0.2%

Stay in the know with updates to Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Enter your email address, and we'll notify you when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.